Litcius/Paper detail

Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics

Mingxuan Ding, Kenta Teruya, Weiguanliu Zhang, Hae Weon Lee, Jue Yuan, Ayumi Oguma, Aaron Foutz, Manuel V. Camacho, Marcus Mitchell, Justin J. Greenlee, Qingzhong Kong, Katsumi Doh‐ura, Li Cui, Wen‐Quan Zou

2021Molecular Neurobiology21 citationsDOIOpen Access PDF

Abstract

Abstract Previous studies have revealed that the infectious scrapie isoform of prion protein (PrP Sc ) harbored in the skin tissue of patients or animals with prion diseases can be amplified and detected through the serial protein misfolding cyclic amplification (sPMCA) or real-time quaking-induced conversion (RT-QuIC) assays. These findings suggest that skin PrP Sc -seeding activity may serve as a biomarker for the diagnosis of prion diseases; however, its utility as a biomarker for prion therapeutics remains largely unknown. Cellulose ethers (CEs, such as TC-5RW), widely used as food and pharmaceutical additives, have recently been shown to prolong the lifespan of prion-infected mice and hamsters. Here we report that in transgenic (Tg) mice expressing hamster cellular prion protein (PrP C ) infected with the 263K prion, the prion-seeding activity becomes undetectable in the skin tissues of TC-5RW-treated Tg mice by both sPMCA and RT-QuIC assays, whereas such prion-seeding activity is readily detectable in the skin of untreated mice. Notably, TC-5RW exhibits an inhibitory effect on the in vitro amplification of PrP Sc in both skin and brain tissues by sPMCA and RT-QuIC. Moreover, we reveal that TC-5RW is able to directly decrease protease-resistant PrP Sc and inhibit the seeding activity of PrP Sc from chronic wasting disease and various human prion diseases. Our results suggest that the level of prion-seeding activity in the skin may serve as a useful biomarker for assessing the therapeutic efficacy of compounds in a clinical trial of prion diseases and that TC-5RW may have the potential for the prevention/treatment of human prion diseases.

Topics & Concepts

ScrapieBiomarkerHamsterChronic wasting diseasePrion proteinVirologyMesocricetusBiologyTransgeneGene isoformProteaseMolecular biologyChemistryBiochemistryPathologyDiseaseEnzymeMedicineGenePrion Diseases and Protein Misfolding
Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics | Litcius